Drug
Atezolizumab Injection [Tecentriq]
Atezolizumab Injection [Tecentriq] is a pharmaceutical drug with 4 clinical trials. Currently 1 active trials ongoing. Historical success rate of 100.0%.
Total Trials
4
Max Phase
—
Type
DRUG
Molecule
—
Success Metrics
Clinical Success Rate
100.0%
Based on 1 completed trials
Completion Rate
100%(1/1)
Active Trials
1(25%)
Results Posted
0%(0 trials)
Phase Distribution
Ph phase_4
1
25%
Ph phase_2
3
75%
Phase Distribution
0
Early Stage
3
Mid Stage
1
Late Stage
Phase Distribution4 total trials
Phase 2Efficacy & side effects
3(75.0%)
Phase 4Post-market surveillance
1(25.0%)
Highest Phase Reached
Phase 4Trial Status & Enrollment
Completion Rate
50.0%
1 of 2 finished
Non-Completion Rate
50.0%
1 ended early
Currently Active
1
trials recruiting
Total Trials
4
all time
Status Distribution
Active(1)
Completed(1)
Terminated(1)
Other(1)
Detailed Status
Active, not recruiting1
Withdrawn1
unknown1
Completed1
Development Timeline
Analytics
Development Status
Total Trials
4
Active
1
Success Rate
100.0%
Most Advanced
Phase 4
Trials by Phase
Phase 23 (75.0%)
Phase 41 (25.0%)
Trials by Status
active_not_recruiting125%
withdrawn125%
unknown125%
completed125%
Recent Activity
1 active trials
Showing 4 of 4
withdrawnphase_2
Efficacy and Safety of VB10.16 Alone or in Combination With Atezolizumab in Patients With Advanced Cervical Cancer.
NCT06099418
completedphase_4
Evaluation of Blood TMB for the Efficacy of Atezolizumab [BUDDY]
NCT04059887
active_not_recruitingphase_2
Efficacy of Atezolizumab Concurrent With Radiotherapy in Patients With Muscle-invasive Bladder cáncer
NCT04186013
unknownphase_2
Efficacy and Safety of T+A+RAD in HCC
NCT05396937
Clinical Trials (4)
Showing 4 of 4 trials
NCT06099418Phase 2
Efficacy and Safety of VB10.16 Alone or in Combination With Atezolizumab in Patients With Advanced Cervical Cancer.
NCT04059887Phase 4
Evaluation of Blood TMB for the Efficacy of Atezolizumab [BUDDY]
NCT04186013Phase 2
Efficacy of Atezolizumab Concurrent With Radiotherapy in Patients With Muscle-invasive Bladder cáncer
NCT05396937Phase 2
Efficacy and Safety of T+A+RAD in HCC
All 4 trials loaded
Drug Details
- Intervention Type
- DRUG
- Total Trials
- 4